WebDr. Sierk Poetting Ph.D. MD, COO & Member of Management Board: 1.01M: N/A: ... BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious ... WebApr 13, 2024 · BIONTECH SE : Cotizaciones de la bolsa, gráficos, consejos de bolsa, datos financieros, análisis y noticias en tiempo real de la acción BIONTECH SE B1NT34 BRB1NTBDR005 Bolsa de Valores de Sao Paulo ... Sierk Poetting: Chief Operating Officer: Más información sobre la empresa. Sector y competencia. Var. 1Ene: Capi. (M$) …
BioNTech to open mRNA facility in Melbourne
WebMar 14, 2024 · "This is a historic moment," said BioNTech's chief operating officer Sierk Poetting. The Covid-19 pandemic exposed Africa's huge dependence on imported vaccines. WebDr. Sierk Poetting is our Chief Operating Officer. Dr. Poetting joined BioNTech in September 2014 from Novartis, where he served in various positions and from May 2012 to August 2014 as Vice President and Chief Financial Officer for the Sandoz Division in North America. Dr. Poetting started his career as a consultant with McKinsey & Company. greater city of sudbury waste management
BIONTECH SE : Precio Acción Bourse B1NT34 BRB1NTBDR005
WebFeb 16, 2024 · BioNTech, which produced the first MRNA jab, has developed a "laboratory in a container", which could be shipped to several countries. ... Dr Poetting, who came … WebSep 1, 2014 · Mainz biopharmaceutical company BioNTech AG has announced that as of September 1, 2014 Mr. Sierk Pötting will join the management team of BioNTech AG as CFO (Chief Financial Officer), succeeding ... WebAge : 49. Public asset : 79,025,034 USD. Country of residence : Unknown. Linked companies : BioNTech SE. Biography of Sierk Pötting. Currently, Sierk Pötting occupies the position of Chief Operating & Financial Officer for BioNTech SE and Co-Managing Director at JPT Peptide Technologies GmbH and Managing Director at BioNTech Small … flinch though still game